期刊文献+

C3肾小球肾炎一例并文献复习

原文传递
导出
摘要 C3肾小球痫指发病与补休激活、沉积和降解异常有炎,以突出的肾小球C3片段沉积和电镜下致密物沉积为特矩的肾小球疾病,包括C3肾小球肾炎(C3GN)和敛密物沉积病(DDD)两种亚型。
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2015年第9期703-704,共2页 Chinese Journal of Nephrology
基金 中央高校基本科研基金(21615473)
  • 相关文献

参考文献9

  • 1Pickering MC,DvAgati VD,Nester CM,et al.C3 glomerulopathy: consensus report[J].Kidney Int,2013,84(6):1079-1089.
  • 2Fakhouri F,Fremeaux-Bacchi V,Noel LH,et al.C3 glomerulopathy:a new classification[J].Nat Rev Nephrol,2010,6(8):494-499.
  • 3Verroust PJ,Wilson CB,Cooper NR,et al.Glomerular complement components in human glomerulonephritis[J].J Clin Invest,1974,53(1):77-84.
  • 4Gale DP,de Jorge EG,Cook HT,et al.Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis[J].Lancet,2010,376(9743):794-801.
  • 5梁兰青.C3肾小球病[J].临床肾脏病杂志,2012,12(3):102-104. 被引量:4
  • 6章海涛,陈惠萍,曾彩虹,邓康平,李世军,郑春霞,刘志红.C3肾小球肾炎的临床表现及病理特征[J].肾脏病与透析肾移植杂志,2011,20(4):307-311. 被引量:17
  • 7Servais A,Noel LH,Roumenina LT,et al.Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies[J].Kidney Int,2012,82(4):454-464.
  • 8Lapeyraque AL,Fremeaux-Bacchi V,Robitaille P.Efficacy of eculizumab in a patient with factor-H-associated atypical hemolytic uremic syndrome[J].Pediatr Nephrol,2011,26(4):621-624.
  • 9Payette A,Patey N,Dragon-Durey MA,et al.A case of C3 glomerulonephritis successfully treated with eculizumab[J]. Pediatr Nephrol,2015,30(6):1033-1037.

二级参考文献14

  • 1Servais A, Freemeaux-Bacchi V, Lequintrec M, et al. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J Med Genet,2007,44(3 ) :193 -199.
  • 2Fakhouri F, Fremeaux-Bacchi V, Noel LH, et al. C3 glomerulopathy : a new classification. Nat Rev Nephrol, 2010,6 ( 8 ) :494 - 499.
  • 3Picketing MC, Cook HT. Translational mini-review series on complement factor H:renal diseases associated with complement factor H:novel insights from humans and animals. Clin Exp Immuno1,2008, 151 (2) :210 -230.
  • 4Rose KL,Paixao-Cavalcante D, Fish J, et al. Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice. J Clin Invest, 2008,118 ( 2 ) :608 - 618.
  • 5Welch TR. The complement system in renal diseases. Nephron,2001, 88(3) :199 -204.
  • 6Appel GB, Cook HT, Hageman G, et al. Membranoproliferative glomerulonephritis type II ( dense deposit disease) : an update. J Am Soc Nephro1,2005,16 (5) : 1392 - 1403.
  • 7Pickering M, Cook HT. Complement and glomerular disease: new insights. Curr Opin Nephrol Hypertens,2011,20 ( 3 ) : 271 - 277.
  • 8Walker PD, Ferrario F, Joh K, et al. Dense deposit disease is not a membranoproliferative glomerulonephritis. Mod Pathol, 2007,20 ( 6 ) : 605 -616.
  • 9Smith R J, Alexander J, Barlow PN, et al. New approaches to the treatment of dense deposit disease. J Am Soc Nephro1,2007,18 (9) : 2447 - 2456.
  • 10甄军晖,孙海平.膜增生.肾性肾小球肾炎和致密物沉积病//黎磊石,刘志红.中国肾脏病学.北京:人民军医出版社,2008:402-421.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部